BIIB

Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke — Head of Investor Relations Christopher…

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net…

Biogen Inc. (NASDAQ: BIIB) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Mike Hencke — Head, Investor Relations Michel Vounatsos — Chief…

Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit…

Biogen Inc (NASDAQ: BIIB) Q2 2022 Earnings Conference

Biogen Inc.  (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke — Head of Investor Relations. Michel…

Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net…

Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition…

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net…

Biogen Inc (NASDAQ: BIIB) Q4 2021 Earnings Conference